Canadian Biomaterials Society
La Société Canadienne des Biomatériaux

Dear CBS members, Greetings The Montreal Student Chapter of the Canadian Biomaterials Society is thrilled to invite you to a CBS Lunchtime webinar series talk and a lab tour on April 10th This event will feature an online presentation by Professor Darcy Wagner from McGill University at noon and an in-person lab tour starting at 4 30pm meet at RI-MUHC, Bloc E Atrium ...

Dear CBS Members, This is a friendly reminder that the abstract deadline for CBS2025 is today Submit your abstracts here...

Calling all ECR Faculty Members for Keynote Presentation Opportunities Dear CBS Members, A feature of CBS2025 will be presentations from current Early Career Researcher ECR faculty member highlighting their expertise and new research...

CBS2025 abstract submission deadline is extended until February 7th We know it is a busy time of year and so we are happy to announce that the CBS 2025 abstract submission deadline for the 39th Annual Meeting of the Canadian Biomaterial Society has been extended until February 7th, 2025 please note that this will be the last extension The CBS2025 Organizing Committee invites you to submit your abstracts related to biomaterials research through the Oxford Abstracts submission portal...

Dendritic cells DCs are antigen-presenting cells and play an essential role in bridging the innate and adaptive immune responses 1 ...

3D bioprinting allows the fabrication of complex architecture by layer-by-layer deposition of cells embedded in biomaterials...

Alternatives to existing implantable materials ex. metals or autologous grafts for bone tissue repair and regeneration are needed to improve patient outcomes and avoid the complications caused by issues such as stress shielding and donor site morbidity 1 ...

Development of biomaterials for regeneration of soft tissues still faces critical challenges related to control of cell phenotype and the prevention of contraction scar tissue formation upon implantation...

Bringing drugs capable of treating neurological diseases and disorders to market requires large amounts of both time and money...